81. Search By Disease Galactorylceramide beta galactosidase deficiency. 10, Galactose1-phosphateuridylyltransferase (galt). 11, Galactose-1-phosphate uridylyltransferase http://www.eddnal.com/directory/disease.php?letter=G

82. GlycoWord / GlycogeneA-01 To understand the effects of the 1,4-galt-I deficiency on carbohydrate structures,N-glycans and O-glycans in various tissues of -1,4-galt-I KO mice were http://www.glycoforum.gr.jp/science/word/glycogene/GGA01.html

-1,4-Galactosyltransferase ( -1,4-GalT) Gene KO Mice -1,4-Galactosyltransferase ( -1,4-GalT) (EC 2.4.1.38) is a glycosyltransferase that is required for the biosynthesis of the backbone structure from type 2 chain (Gal 4GlcNAc), which appears widely on N-glcans, O-glycans and glycolipids. The type 2 chain is particularly important in the synthesis of sialyl lewis x and SSEA-1, which play a role in the immune system and early embryogenesis, respectively. Although -1,4-GalT gene was believed to be a single gene in the past, novel -1,4-GalT genes were successively isolated in 1997-1998 to form the -1,4-GalT gene family consisting of seven genes. KO mice deficient in the -1,4-GalT activity and faint bands corresponding to the Gal 4GlcNAc structure detected in -1,4-GalT-I KO mice could be derived from other -1,4-GalT gene(s). -1,4-GalT-I KO mice were unexpectedly born normally, although an essential role of the Gal -1,4-GalT-I KO mice showed augmented proliferation and abnormal differentiation of intestinal and epidermal epithelial cells, suggesting the carbohydratechains synthesized by -1,4-GalT-I regulate proliferation and differentiation of epithelial cells (1).

83. Requisition For Molecular Diagnostic Services FRAGILE X SYNDROME; FRIEDREICH S ATAXIA; GALACTOSEMIA (galactose1-phosphateuridyl transferase (galt) deficiency); HEMOCHROMATOSIS (HFE); HEMOGLOBIN C http://www.compgene.com/reqweb.htm

Requisition for Molecular Diagnostic Services Comprehensive Genetic Services SC, 3720 North 124th Street, Milwaukee, WI 53222 Toll free (877) COMPGENE or (414) 393 - 1000, FAX: (414) 393 - 1399 E-mail: compgene@worldnet.att.net PLEASE CHECK ALL APPROPRIATE BOXES AND HAVE PATIENT READ AND COMPLETE CONSENT FORM This requisition form and the consent form can be printed directly from your WWW browser. The requisition form should be two pages while the consent form should be one page. QUESTIONS? PLEASE CONSULT WITH LAB PATIENT INFORMATION DATE (MM/DD/YY): PATIENT NAME: DATE of BIRTH(MM/DD/YY): YOUR PATIENT ID# (if desired): REFERRING PHYSICIAN: ADDRESS TO SEND REPORT: ADDRESS TO SEND INVOICE: ETHNIC ORIGIN: Caucasian African American Hispanic Asiatic American Indian SAMPLE TYPE: Blood (1-2 x 5-7 ml EDTA (PURPLE VACUTAINER / 1 X 3 ml EDTA (newborn/infant only) Amniotic fluid (volume required dependent on assay) Chorionic villi ( 5 - 10 mg in PBS/medium) Amniocytes (at least 1 confluent T25 required) Other (Please consult with CompGene) DATE SAMPLE OBTAINED(MM/DD/YY): INDICATION: CONFIRMATION OF DIAGNOSIS CARRIER STATUS PRENATAL TESTING Date of LMP: FAMILY HISTORY? (Please FAX or enclose pedigree with samples)

84. BioMed Central | Full Text | The Clinical And Molecular Spectrum Of Galactosemia Transferasedeficiency galactosemia usually presents in the neonatal period It is not surprising therefore, that 5 of the 6 galt alleles from patients http://www.biomedcentral.com/1471-2431/2/7

home journals A-Z subject areas advanced search ... Volume 2 Viewing options Abstract Full text PDF Associated material: Pre-publication history PubMed record Related literature: Articles citing this article on Google Scholar Other articles by authors Henderson H ... Similar articles (PubMed) Tools: E-mail to a friend Download references Post a comment Key E-mail Corresponding author Research article The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa Howard Henderson Felicity Leisegang Ruth Brown and Brian Eley Department of Chemical Pathology and School of Child and Adolescent Health, Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa Dept of Pediatrics, and School of Child and Adolescent Health, Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa BMC Pediatrics The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2431/2/7 Received Accepted Published Outline Abstract Abstract Background Methods Results ... Pre-publication history Background The objective of this study was to document the clinical, laboratory and genetic features of galactosemia in patients from the Cape Town metropolitan region.

85. Zinc Deficiency Impairs Immune Responses Against Parasitic Nematode Infections A galt in intestinal infections Evidence that zinc deficiency Experimental modelH. polygyrus Effect of zinc deficiency http://www.nutrition.org/cgi/content/full/130/5/1412S

QUICK SEARCH: [advanced] Author: Keyword(s): Year: Vol: Page: This Article Abstract Full Text (PDF) Alert me when this article is cited ... Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager ... Cited by other online articles PubMed PubMed Citation Articles by Scott, M. E. Articles by Koski, K. G. Journal of Nutrition. The American Society for Nutritional Sciences Supplement Zinc Deficiency Impairs Immune Responses against Parasitic Nematode Infections at Intestinal and Systemic Sites Marilyn E. Scott and Kristine G. Koski Institute of Parasitology, School of Dietetics and Human Nutrition, McGill University, Macdonald Campus, Ste-Anne de Bellevue, Quebec H9X 3V9, Canada To whom correspondence should be addressed. ABSTRACT TOP ABSTRACT INTRODUCTION GALT in intestinal infections Evidence that zinc deficiency... Experimental model: H. polygyrus... Effect of zinc deficiency... Suggestions for future research REFERENCES Research on the complex interactions among host nutritional status, parasitic infection and immune responsiveness has focused

86. Wisconsin Newborn Screening Laboratory: The genetic disturbance is expressed as a cellular deficiency of either Although detection of classical galactosemia using the galt enzyme test is not http://www.slh.wisc.edu/newborn/guide/galactosemia.php

WSLH Newborn Guide Galactosemia ... Advisory Committee Health Professionals Guide to Newborn Screening: Newborn Screening Disorders Galactosemia Autosomal recessive disorder of galactose metabolism. The genetic disturbance is expressed as a cellular deficiency of either galactose-1-phosphate uridyl transferase (classic form), galactokinase, (variant) or uridine diphosphate galactose 4 epimerase (variant) - the enzymes catalyzing the reaction by which galactose is converted to glucose. The main dietary source of galactose is lactose, the principle carbohydrate in milk. Prevalence (WI): Analyte Measured: Galactose-1-Phosphate Uridyl-1-Transferase (GALT) Abnormal Levels: Lack of GALT enzyme activity Feeding Effect: NONE (See COMMENT below) Timing Effect: 24 hours of age: Results are valid Confirmation: Quantitative plasma metabolites Quantitative enzyme activity Mutation analysis Treatment: Elimination of dietary lactose, including breast milk, cow’s milk and/or lactose-based infant formula.

87. Galactose-1-phosphate Uridylyltransferase A deficiency of galt results in a clinical manifestation termed “classicgalactosemia” which may present a range of problems including neurological http://www.arches.uga.edu/~dan/bcmb8010/

Please note these web pages are part of an assignment for a graduate course in Advanced Biochemistry and Molecular Biology BCMB8010 at the University of Georgia. Questions should be directed to Dan Sherling (dan@uga.edu) Structure of Galactose-1-phosphate uridylyltransferase (GALT) and it’s function in the Leloir Pathway The three steps of the Leloir pathway allows galactose (Gal), a metabolite of lactose, to enter the myrad of glucose (Glc) metabolic pathways by the conversion of Gal into UDP-glucose (UDP-Glc). In the first step, Gal is converted to galactose-1-phosphate (Gal1P) by galactokinase (GALK). Secondly, galactose-1-phosphate uridylyltransferase (GALT) catalyzes the transfer of one UMP from UDP-Glc to Gal1P, resulting in the production of Glc1P and UDP-galactose (UDP-Gal). UDP-Gal is then epimerized at the C4 position to produce UDP-Glc in the third (and final) step of the pathway by UDP-Gal epimerase (GALE). Glc1P may enter glycolysis through the conversion into Glc6P by phosphoglucomutase. In this report we will focus on the structure and function of the second enzyme in the Leloir pathway, GALT. GALT, a 379 amino acid homodimer in humans, catalyzes a double displacement reaction displaying ping-pong kinetics. First, UDP-Glc binds the enzyme through the nucleophilic attack of the enzyme’s His166 on the ?-phosphoryl of UDP-Glc. Glc1P is released, producing an uridylylated enzyme intermediate. The accepted mechanism shows GALT as being the only enzyme in the pathway that proceeds through a covalently bound intermediate. Secondly, Gal1P, from the GALK reaction, binds UMP at the enzyme’s active site, releasing UDP-Gal and regenerating the enzyme.

88. • ACADM deficiency see mediumchain acyl-coenzyme A dehydrogenase deficiency Acid beta-glucosidase deficiency see Gaucher disease, type 1 http://www.urinator.com/testsavailable.htm

A-T see ataxia-telangiectasia AAT see alpha-1 antitrypsin deficiency Absence of vas deferens see congenital bilateral absence of vas deferens Absent vasa see congenital bilateral absence of vas deferens ACADM deficiency see medium-chain acyl-coenzyme A dehydrogenase deficiency ACADVL see very long-chain acyl-coenzyme A dehydrogenase deficiency see achondrogenesis, type 1B see achondrogenesis, type 2 ACH see achondroplasia achondrogenesis, type 1B achondrogenesis, type 2 achondroplasia Acid beta-glucosidase deficiency see Gaucher disease, type 1 Acrocephalosyndactyly (Apert) see Apert syndrome acrocephalosyndactyly, type V see Pfeiffer syndrome Acrocephaly see Apert syndrome Acute cerebral Gaucher's disease see Gaucher disease, type 2 acute intermittent porphyria ACY2 deficiency see Canavan disease acyl-CoA dehydrogenase very long chain deficiency see very long-chain acyl-coenzyme A dehydrogenase deficiency AD see Alzheimer disease Adelaide-type craniosynostosis see Muenke syndrome Adenomatous Polyposis Coli see familial adenomatous polyposis Adenomatous Polyposis of the Colon see familial adenomatous polyposis ADP see ALAD deficiency porphyria Adrenal Gland Disorders see 21-hydroxylase deficiency Adrenogenital Syndrome see 21-hydroxylase deficiency AIP see acute intermittent porphyria AIS see androgen insensitivity syndrome AKU see alkaptonuria 5-ALA dehydratase-deficient porphyria see ALAD deficiency porphyria ALA-D porphyria see ALAD deficiency porphyria ALA dehydratase porphyria see ALAD deficiency porphyria ALAD deficiency porphyria Alagille syndrome Alcaptonuria

89. Chromatographia Online - July 54 Abstracts When applied to 11 anonymous blood spots of heterogeneous genotypes of GALTdeficiency all of the patients blood samples showed abnormal elevation of http://www.chromatographia.de/daten/july_54_abstracts.htm

CHROMATOGRAPHIA An International Journal for Rapid Communication in Chromatography, Electrophoresis, and Associated Techniques Contents Volume (Issue): 54 July (1/2) 2001 Previous Issue Issue Listing Next Issue Some Studies of the Chromatographic Properties of Gels ('Artificial Antibodies/Receptors') for Selective Adsorption of Proteins D. Tong / Cs. Hetényi / Zs. Bikádi / J.-P. Gao / S. Hjertén non -charged monomers (acrylamide and N,N' Another universal method has been introduced for rapid screening of potential monomers and gels for the preparation of selective adsorbents. This very simple method is based on the assumption that the absorption maximum of a protein changes when the protein interacts with the free monomers or the adsorbent synthesized from the monomers (and does not change when the protein does not interact). Preliminary docking experiments indicate that selective adsorption of the protein by the polyacrylamide matrix is based primarily on hydrogen-bonding and dipole-dipole interactions. The strengths of these interactions can be varied by choosing different gel matrices (for removal of a given protein the interactions should be very strong, whereas they should be weaker for chromatographic analysis). Determination of the Antibiotic Zinc Bacitracin in Animal Food by High-Performance Liquid Chromatography with Ultraviolet Detection L. F. Capitán-Vallvey / N. Navas / A. Titos / R. Checa

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 5     81-89 of 89    Back | 1  | 2  | 3  | 4  | 5